Ryan Specialty (NYSE:RYAN) Issues Earnings Results

Ryan Specialty (NYSE:RYAN) issued its quarterly earnings data on Thursday. The company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.02, FiscalAI reports. The company had revenue of $789.96 million during the quarter, compared to analysts’ expectations of $792.99 million. Ryan Specialty had a return on equity of 45.09% and a net margin of 8.25%. During the same quarter in the previous year, the business earned $0.47 earnings per share.

Here are the key takeaways from Ryan Specialty’s conference call:

• Third-quarter results remained resilient: revenue increased 4.7% to $790 million, organic growth was 4%, adjusted EBITDAC rose 3.8% to $244 million, and adjusted EPS grew 8.5% to $0.51 despite a difficult comparison.
• Market conditions are becoming more competitive, with continued property pricing declines, broader casualty competition, new capacity in delegated authority, and softness in builders risk. Management expects further property pricing deterioration in the fourth quarter and into 2027, while full-year adjusted EBITDAC margin is expected to decline modestly.
• Management raised its 2026 outlook for organic revenue growth to the higher end of its mid-single-digit range and cited cost discipline, Empower efficiencies, strong producer retention, and the eventual accretion of its late-2025 hiring class as margin and growth tailwinds.
• Ryan Specialty is expanding AI-related insurance offerings and internal automation, including a $625 million GPU facility and expanded transit coverage of up to $100 million per shipment. The company also repurchased $150 million of shares in the quarter and had $100 million remaining under its authorization.
• Management sees potential for a more active M&A environment in 2027 and continued growth in reinsurance, delegated authority, data-center infrastructure, and other complex specialty risks, supported by strong client demand and the company’s specialty distribution platform.

Ryan Specialty Price Performance

Ryan Specialty stock traded up $0.55 during mid-day trading on Friday, reaching $43.83. The company had a trading volume of 3,157,195 shares, compared to its average volume of 1,927,373. Ryan Specialty has a 1 year low of $29.28 and a 1 year high of $58.94. The company has a debt-to-equity ratio of 3.51, a current ratio of 1.00 and a quick ratio of 1.00. The company has a market capitalization of $11.21 billion, a P/E ratio of 54.11, a P/E/G ratio of 0.89 and a beta of 0.61. The stock’s 50-day simple moving average is $40.42 and its 200-day simple moving average is $39.17.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 24th. Shareholders of record on Tuesday, November 10th will be given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.2%. The ex-dividend date is Tuesday, November 10th. Ryan Specialty’s dividend payout ratio is presently 64.20%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Royal Bank Of Canada reduced their target price on shares of Ryan Specialty from $55.00 to $52.00 and set an “outperform” rating for the company in a report on Friday. UBS Group boosted their target price on Ryan Specialty from $50.00 to $55.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Morgan Stanley upped their price target on Ryan Specialty from $48.00 to $50.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 19th. Atlantic Securities set a $69.00 price target on Ryan Specialty in a report on Wednesday, July 15th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of Ryan Specialty from $48.00 to $54.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Eight equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $52.03.

Key Ryan Specialty News

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q3 earnings exceeded expectations: Ryan Specialty reported adjusted EPS of $0.51, up from $0.47 a year earlier and above the $0.49 analyst consensus. Revenue increased 4.7% to approximately $790 million, while net income rose 40.6% to $88 million. Ryan Specialty Q3 earnings and revenue beat estimates
• Positive Sentiment: Capital returns remain supportive: The company returned $173.7 million to shareholders during the quarter, including $150 million in share repurchases. It also declared a quarterly dividend of $0.13 per share, equivalent to a $0.52 annualized payout and roughly a 1.2% yield.
• Positive Sentiment: RBC remains bullish: Royal Bank of Canada maintained an “outperform” rating, implying substantial upside from recent levels, although it reduced its price target from $55 to $52. RBC lowers Ryan Specialty price target
• Neutral Sentiment: Analyst sentiment is mixed: Ryan Specialty received a “hold” rating from a broader group of Wall Street analysts, balancing RBC’s positive view and the company’s earnings performance.
• Negative Sentiment: Organic growth slowed: Q3 organic revenue growth was 4%, raising concerns that expansion is moderating despite the earnings beat. The company maintained its full-year mid-single-digit organic growth outlook. Ryan Specialty organic growth slows to 4%
• Negative Sentiment: Profitability guidance softened: Management indicated that full-year adjusted EBITDAC margin could decline by roughly 50 basis points from the prior year, creating a headwind for valuation and future earnings growth.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.